cannadelics.com
Epidiolex Launch in U.S. Prompts GW Pharmaceuticals Sales Surge
BRITISH cannabis firm GW Pharmaceuticals is close to securing European approval for its Epidiolex drug after seeing its success in the U.S.
Peter McCusker
